Perspective Therapeutics, Inc. — Director's Dealing 2018

Mar 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2018-03-14

Reporting Person: Vitale Philip J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-14	Common Stock	P	10000	$0.4399	Acquired	80000	Direct